Latest
Sources
Trade Ideas
Speakers
Sign in
Go
Goldman Sachs Maintains Neutral on Moderna, Raises Price Target to $41
Original source ↗
| February 17, 2026 at 13:57 UTC |
Finnhub - MRNA
No analysis available.
Trade Ideas
Ticker
Direction
Speaker
Thesis
Time
MRNA
NONE
Finnhub News
—
—